Avenue Therapeutics, Inc.

ATXI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$12-$10-$4-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$0
Change in WC$0-$0$0-$0
Other Non-Cash$1$0-$5$0
Operating Cash Flow-$9-$9-$8-$4
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$3$0$0
Investing Cash Flow$0-$3$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2$8$11$5
Stock Repurch.$0$0-$1$0
Dividends Paid$0$0$0$0
Other Fin. Act.$8$0$0-$1
Financing Cash Flow$10$8$11$4
Forex Effect$0$0$0$0
Net Chg. in Cash$1-$5$3$1
Supplemental Information
Beg. Cash$2$7$4$3
End Cash$3$2$7$4
Free Cash Flow-$9-$12-$8-$4